Compare · Ingredients

Cysteamine vs Mandelic Acid

Cysteamine: Can reduce melasma pigmentation in tested topical formulas. Mandelic Acid: Exfoliates skin; clinical evidence is mainly from professional acne peels.

Research updated 2026-10-25

Four cysteamine products: a Senté tube, an Omic+ cream and box, a 5% cysteamine serum dropper and a Cyspera bottle

Five mandelic acid serums and their boxes lined up on white with clear gel swatches

Which one?At a glance What it helps Diagrams Using both Strengths Results Safety How it works Questions

Which one is right for you?

Choose Cysteamine if…

Consider for diagnosed melasma when a suitable topical option is needed.

Diagnosed melasma
Hydroquinone isn’t suitable
You can follow short-contact wash-off

Choose Mandelic Acid if…

Consider for exfoliation; evidence for acne comes mainly from supervised peels.

Acne-prone or darker skin wanting a gentler AHA
Mild texture concerns
Sensitive skin that stings with glycolic

Use care together

Can you use both?

Both can irritate. Use mandelic acid on different nights from cysteamine.

At a glance

● Cysteamine

● Mandelic Acid

Type

Pigment-targeting active

Alpha hydroxy acid (AHA)

What it does

Can reduce melasma pigmentation in tested topical formulas.

Exfoliates skin; clinical evidence is mainly from professional acne peels.

Best for

Melasma

Acne

Studied concentrations

5% cream in controlled melasma trials; contact instructions vary by product.

45% professional peels in the cited acne trial.

When to use

On the schedule specified for the product or prescribed treatment.

Start on a few evenings weekly; increase only if comfortable.

Time to results

Usually assessed over 8–16 weeks

Often 8–12 weeks in small cosmetic studies; results may be subtle

Irritation

Odour, stinging and irritation may limit use; follow wash-off instructions.

Can cause stinging, peeling or irritation; avoid active eczema and rosacea flares.

Sensitive skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Available

Prescription or cosmetic status depends on the active, formula and country; check the label.

Cosmetic or OTC products; some high-strength procedures are separate treatments.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level

Cysteamine

Mandelic Acid

Moderate evidenceSome supportive research

Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

A placebo-controlled trial found reduced pigmentation with 5% cream.

—

Limited evidenceEarly or small studies

—

Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

Professional mandelic peels improved acne in a small comparative trial.

Insufficient evidence

Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trial does not establish fading of every type of dark mark.

The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.

Sensitive Skin on light skin.

Sensitive Skin

The reviewed sources do not establish this ingredient as a treatment for this concern.

Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

The reviewed sources do not establish this ingredient as a treatment for this concern.

Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited acne-peel trial does not establish reliable fading of post-acne marks.

A relaxed forehead with pronounced deep horizontal furrows.

Deep Wrinkles

The reviewed sources do not establish this ingredient as a treatment for this concern.

Redness and fine superficial vessels across a light-skinned cheek and nose.

Rosacea

The reviewed sources do not establish this ingredient as a treatment for this concern.

How it works

Cysteamine mechanism diagram. Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter. — Open full-size diagram
Diagram explanation and sources
Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Source 1

Mandelic Acid mechanism diagram. Loosens outer cells: An acidic formula helps reduce cell adhesion. Promotes shedding: Strength, pH and contact time affect the response. — Open full-size diagram
Diagram explanation and sources
Loosens outer cells: An acidic formula helps reduce cell adhesion. Promotes shedding: Strength, pH and contact time affect the response.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Source 1 · Source 2

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning

Step 1

Cleanser

Step 2

Moisturizer

Step 3

Sunscreen

Night

Step 1

Cleanser

Step 2

Mandelic AcidNight

Step 3

CysteamineNight

Step 4

Moisturizer

Strengths and forms

Concentrations

5% cysteamine cream is the main concentration studied for melasma. Contact time is product-specific; some studied formulas are short-contact treatments rather than overnight creams.

5%

Studied melasma cream

Controlled trials studied this strength. One short-contact trial used a specific cream; follow the current product’s instructions rather than copying a study schedule.

Choosing a strength: Choose a finished topical product with clear instructions for how long to leave it on and when to rinse.

Higher strengths: There is no established benefit from escalating beyond the studied strength. Burning, redness or a persistent rash are reasons to stop and reassess.

Formula matters: Stabilization, the base cream and exposure time affect tolerability. Different cysteamine formulations need not have identical instructions.

Mandelic acid skincare and office peels are different products. Controlled acne studies have used professional peels around 40–45%; those strengths are not a target for facial home use.

40–45%

Studied professional peels

Clinician-applied peels studied for mild-to-moderate acne. This describes specific procedures, not a recommended home concentration.

Choosing a strength: For home skincare, use the finished product’s label and your tolerance. Do not assume that a marketed serum reproduces an office peel study.

Higher strengths: Mandelic acid can still burn or irritate skin. Being described as a gentler acid does not make concentrated peels suitable for unsupervised use.

Formula matters: Acidity, vehicle and exposure time influence the effect; percentage alone cannot rank safety or compare mandelic acid with other acids.

Forms

Cream

Serum · Toner · Peel

When you’ll see results

Approximate windows, not promises.

● Cysteamine

● Mandelic Acid

First few weeks

First few weeksAssess tolerance first; pigment change is usually slower.

First few weeksAssess tolerance and texture; immediate softness can come from the base formula.

4–8 weeks

4–8 weeksSome studied regimens begin showing pigment improvement.

4–8 weeksSubtle changes may appear in some tested products; evidence varies.

8–12 weeks

8–12 weeksA useful review point for benefit and irritation.

8–12 weeksCompare photographs in the same lighting and reassess benefit.

3–6 months

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.

6–12 months

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.

Safety and sensitive skin

Common reactions

Odour, stinging and irritation may limit use; follow wash-off instructions.

Can cause stinging, peeling or irritation; avoid active eczema and rosacea flares.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Important limits

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

Data in pregnancy are limited; ask the clinician managing your pregnancy before using.

Low-strength leave-on acids are generally considered acceptable; avoid peels and ask the clinician managing your pregnancy.

How it works

In the skin

On the skin. The finished product delivers cysteamine in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Acts on pigment-related pathways; the cream, contact time and tolerance influence its practical effect.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers mandelic acid in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Promotes shedding of surface cells; formula acidity and contact time influence irritation and effect.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in

Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Molecule size

Cysteamine · 77 Da

Mandelic Acid · 152 Da

Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.

500 Da guideline

Common questions

Cysteamine:What should I choose cysteamine for?

Consider for diagnosed melasma when a suitable topical option is needed.

Cysteamine:How strong is the evidence?

A small placebo-controlled study supports 5% cream over four months. Active-comparator studies are small and do not prove equal efficacy to hydroquinone. The mass shown refers to the free base, not its hydrochloride salt.

Mandelic Acid:What should I choose mandelic acid for?

Consider for exfoliation; evidence for acne comes mainly from supervised peels.

Mandelic Acid:How strong is the evidence?

A 50-person, 12-week trial compared 45% mandelic with 30% salicylic peels. It had no vehicle arm and does not establish the benefit of 5–10% home serums.

Sources

Sources and further reading

Dermapedia on YouTube